Hypericin -: The facts about a controversial agent

被引:199
作者
Kubin, A
Wierrani, F
Burner, U
Alth, G
Grünberger, W
机构
[1] Ludwig Boltzmann Inst Clin Oncol & Photodynam The, Vienna, Austria
[2] Hosp Rudolfstiftung, Dept Gynecol & Obstet, Vienna, Austria
[3] Vienna Soc Photodynam Diagnosis & Photodynam Ther, Vienna, Austria
关键词
fluorescence diagnosis; photodynamic therapy (PDT); photophysical diagnosis (PPD); antiviral; antiretroviral; photosensitizer;
D O I
10.2174/1381612053382287
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hypericin is a naturally occurring substance found in the common St. Johns Wort (Hypericum species) and can also be synthesized from the anthraquinone derivative emodin. As the main component of Hypericum perforatum, it has traditionally been used throughout the history of folk medicine. In the last three decades, hypericin has also become the subject of intensive biochemical research and is proving to be a multifunctional agent in drug and medicinal applications. Recent studies report antidepressive, antineoplastic, antitumor and antiviral (human immunodeficiency and hepatitis C virus) activities of hypericin; intriguing information even if confirmation of data is incomplete and mechanisms of these activities still remain largely unexplained. In other contemporary studies, screening hypericin for inhibitory effects on various pharmaceutically important enzymes such as MAO (monoaminoxidase), PKC (protein kinase Q, dopamine-beta-hydroxylase, reverse transcriptase, telomerase and CYP (cytochrome P450), has yielded results supporting therapeutic potential. Research of hypericin and its effect on GABA-activated (gamma amino butyric acid) currents and NMDA (Nmethyl-D-aspartat) receptors also indicate the therapeutic potential of this substance whereby new insights in stroke research (apoplexy) are expected. Also in the relatively newly established fields of medical photochemistry and photobiology, intensive research reveals hypericin to be a promizing novel therapeutic and diagnostic agent in treatment and detection of cancer (photodynamic activation of free radical production). Hypericin is not new to the research community, but it is achieving a new and promizing status as an effective agent in medical diagnostic and therapeutic applications. New, although controversial data, over the recent years dictate further research, re-evaluation and discussion of this substance. Our up-to-date summary of hypericin, its activities and potentials, is aimed to contribute to this process.
引用
收藏
页码:233 / 253
页数:21
相关论文
共 184 条
  • [1] Hypericin in cancer treatment: more light on the way
    Agostinis, P
    Vantieghem, A
    Merlevede, W
    de Witte, PAM
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2002, 34 (03) : 221 - 241
  • [2] Apoptotic and anti-apoptotic signaling pathways induced by photodynamic therapy with hypericin
    Agostinis, P
    Assefa, Z
    Vantieghem, A
    Vandenheede, JR
    Merlevede, W
    De Witte, P
    [J]. ADVANCES IN ENZYME REGULATION, VOL 40, 2000, 40 : 157 - 182
  • [3] PHOTOSENSITIZED INHIBITION OF GROWTH FACTOR-REGULATED PROTEIN-KINASES BY HYPERICIN
    AGOSTINIS, P
    VANDENBOGAERDE, A
    DONELLADEANA, A
    PINNA, LA
    LEE, KT
    GORIS, J
    MERLEVEDE, W
    VANDENHEEDE, JR
    DEWITTE, P
    [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 49 (11) : 1615 - 1622
  • [4] Alecu M, 1998, ANTICANCER RES, V18, P4651
  • [5] Ali SM, 2003, INT J ONCOL, V22, P1181
  • [6] Ali SM, 2002, INT J ONCOL, V21, P531
  • [7] Ali SM, 2002, INT J MOL MED, V9, P461
  • [8] Ali SM, 2002, INT J MOL MED, V9, P601
  • [9] Hypericin and hypocrellin induced apoptosis in human mucosal carcinoma cells
    Ali, SM
    Chee, SK
    Yuen, GY
    Olivo, M
    [J]. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2001, 65 (01) : 59 - 73
  • [10] Ali SM, 2001, INT J MOL MED, V8, P521